Preoperative Methylprednisolone to Patients Suspected of Appendicitis Undergoing Laparoscopy
- Conditions
- Suspected Appendicitis
- Interventions
- Drug: 0.9% Saline
- Registration Number
- NCT02711449
- Lead Sponsor
- Jakob Kleif
- Brief Summary
To test whether 125 mg preoperative methylprednisolone intravenously can reduce postoperative pain after laparoscopy for suspected appendicitis and to test whether preoperative methylprednisolone can reduce postoperative fatigue, increase quality of sleep, reduce nausea or vomiting, reduce duration of convalescence and increase overall quality of recovery after laparoscopy for suspected appendicitis.
- Detailed Description
Patients enrolled are randomized to active substance or placebo approximately 30 minutes prior to skin incision.
Patients are followed for 30 days postoperative with registration of outcomes on a postoperative questionnaire. Patients are contacted by telephone at every registration time. The primary outcome is also secured over the telephone in case patients do not return their questionnaire.
With a power of 80% and a significance level of 5% we need 64 patients (32 in each arm) to show a 30% reduction in postoperative pain during the first 3 postoperative days with 5 measurements and we need 42 patients (21 in each arm) to show a 15% increase in the QoR-15 during the first 3 postoperative days. With an anticipated loss to follow up of 20% we need 80 patients ( 40 in each arm).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 78
- Laparoscopy for suspected appendicitis
- Age 18 years or older
- American Society of Anesthesiologist (ASA) class I-III.
- Gives written and oral consent
- Known inflammatory bowel disease.
- Known autoimmune disease.
- Chronic pain patient.
- Presumed poor compliance.
- Pregnant or breastfeeding.
- In systematic treatment with glucocorticoids or other immunosuppressive treatment.
- Known renal disease, GFR<30.
- Known liver cirrhosis.
- Known heart failure, EF<40%.
- Known glaucoma.
- Known ocular herpes simplex.
- Known cushings disease.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo 0.9% Saline 0.9% Saline intravenously approximately 30 minutes prior to skin incision Methylprednisolone Methylprednisolone 125 mg Methylprednisolone intravenously approximately 30 minutes prior to skin incision
- Primary Outcome Measures
Name Time Method Pain at rest during the first 3 postoperative days on a 11-point NRS 6 hours, 12 hours, postoperative day (POD) 1, POD2 and POD3 Powered to detect 30% reduction, Random regression model (mixed effects model)
- Secondary Outcome Measures
Name Time Method Sleep during the first 3 postoperative days on a 11-point NRS postoperative day (POD) 1, POD2 and POD3 Incidence of postoperative nausea or vomiting during the first postoperative day 6 hours, 12 hours and 24-32 hours postoperative Pain at rest after POD3 on a 11-point NRS postoperative day (POD) 7, POD 14 and POD 30 Fatigue during the first 3 postoperative days on a 11-point NRS 6 hours, 12 hours, postoperative day (POD) 1, POD2 and POD3 Random regression model (mixed effects model)
QoR-15 during the first 3 postoperative days postoperative day (POD) 1, POD2 and POD3 Powered to detect 15% increase,
Pain when coughing during the first 3 postoperative days on a 11-point NRS 6 hours, 12 hours, postoperative day (POD) 1, POD2 and POD3 Random regression model (mixed effects model)
Pain when coughing after POD3 on a 11-point NRS postoperative day (POD) 7, POD 14 and POD 30 Fatigue after POD3 on a 11-point NRS postoperative day (POD) 7, POD 14 and POD 30 QoR-15 after POD 3 postoperative day (POD) 7, POD 14 and POD 30 Mobilization during the first postoperative day on a 4-point likert scale 6 hours, 12 hours and postoperative day 1 Resumption of occupational activity Up to 60 days postoperative Number of days from surgery until resumption of occupational activities
Resumption of recreational activity Up to 60 days postoperative Number of days from surgery until resumption of recreational activities
Duration of convalescence Up to 60 days postoperative Number of days from surgery until resumption of both occupational and recreational activities
Adverse events according to GCP guidelines 30 day postoperative Postoperative complications according to the Clavien-Dindo classification 30 day postoperative Opioid consumption during the first 24 hours postoperative 24 hours postoperative Both as a the need for opioids and the amount equivalent to intravenous morphine.
Need for rescue antiemetics during the first 24 hours postoperative 24 hours postoperative Duration of postoperative hospital stay 30 days postoperative The duration of the postoperative hospital stay in hours.
Sleep after POD3 on a 11-point NRS postoperative day (POD) 7, POD 14 and POD 30
Trial Locations
- Locations (2)
Køge Sygehus
🇩🇰Køge, Denmark
Nordsjaellands Hospital
🇩🇰Hillerød, Denmark